Serum levels of AFP after interferon-based therapy with ribavirin for genotype 4 chronic HCV patients

Impact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy

Serum levels of neopterinin patients with hepatitis C virus relatedchronic liver disease

Serum hepcidin levels in patients with chronic hepatitis C

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Diabetic chronic HCV patients and their response to interferon therapy

Evaluation of post interferon therapy changes in chronic HCV patients : Clinical, Doppler ultrasonography and histopathological study

Viral kinetic changes after 4 weeks and its relation to response to Peg. INF therapy in chronic HCV genotype 4 patients